Metactive Medical

Olathe, United States Founded: 2011 • Age: 15 yrs
Endovascular devices are developed for peripheral and neurovascular disease treatments.

About Metactive Medical

Metactive Medical is a Healthcare company based in Olathe (United States) founded in 2011. Endovascular devices are developed for peripheral and neurovascular disease treatments. Metactive Medical has raised $4.7 million across 5 funding rounds from investors including NIH, Mid America Angels and Serra Ventures. The company has 31 employees. Its focus areas include Life Sciences, Neurology, Medical Devices and Therapeutic Devices. Its legal entity is Artio Medical, Inc. Its competitors include CoAxia and Sequent Medical; 2 of its 2 listed competitors have raised funding.

Company details

Metactive Medical was founded in 2011 and is based in Olathe, United States. Endovascular devices are developed for addressing peripheral and neurovascular diseases within the medical technology sector. The initial product is engineered to facilitate occlusion and sealing of cerebral aneurysms along with other vessel segments, utilizing an over-the-wire microcatheter platform. Operations emphasize innovation in vascular interventions for clinical applications.

Operational Areas
Key Metrics
  • Total Equity Funding
    $4.7M (USD)

    in 5 rounds

  • Latest Funding Round
    $1.2M (USD), Series A

    Mar 2018

  • Investors
    NIH

    & 4 more

  • Employee Count
    31

Funding Insights of Metactive Medical

Metactive Medical has successfully raised a total of $4.7M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $1.2 million completed in March 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $4.7M
  • Total Rounds 5
  • Last Round Series A β€” $1.2M
  • First Round $2M

    (Feb 2015)

  • Investors Count 5

All 5 funding rounds of Metactive Medical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Mar 2018$1.5MGrant––
Mar 2018$1.2MSeries A––
Mar 2017$1.5MSeries A––
Jun 2015$224,000Grant––
Feb 2015$2MSeries A––
Valuation history

5 investors in total: 5 institutional.

Investors in Metactive Medical

Metactive Medical has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include NIH, Mid America Angels and Serra Ventures.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Angel investments are facilitated for US-based startups by Mid-America Angels.
2006midamericaangels.comOverland Park, United States
Venture capital fund focused on Agtech and multiple sectors
serraventures.comChampaign, United States
kansasbioauthority.org
Drug discovery services are provided to the biopharma sector.
1887nih.govUnited States
Research on heart, lung, blood, and sleep disorders is conducted.
nhlbi.nih.govBethesda, United States
Premium access

Investor details for Metactive Medical

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Metactive Medical

3 dated milestones of Metactive Medical across 7 years, from founding to its latest funding, stage changes and deals.

  1. Founded Metactive Medical is founded.
  2. Funding First funding round of $2.0M.
  3. Funding Latest funding round, Series A, of $1.2M.

Competitors of Metactive Medical

Metactive Medical has 2 listed competitors in our database, 2 of them funded. They include CoAxia and Sequent Medical.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
coaxia.com1999Maple Grove, United States$72.6M
Catheter-based treatment for cerebral ischemia
sequentmedical.com2007Aliso Viejo, United States$65.26M1,028
Catheter-based neurovascular devices for aneurysm treatment are developed.
Premium access

Detailed competitors of Metactive Medical

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Neurology

3 companies that operate in the same segment as Metactive Medical (Neurology) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed.
2013San Francisco, California, United StatesUSD 214.78 MUSD 21.05 M211
Developer of therapeutics for psychiatric and neurologic diseases
2002New York, New York, United StatesUSD 80.87 MUSD 250.31 M600
Biologics platform developed for intracellular delivery in rare diseases.
2016Boston, Massachusetts, United StatesUSD 175.25 MUSD 25.42 M183
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Metactive Medical

Premium access

Complete news archive for Metactive Medical

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Metactive Medical

Metactive Medical was founded in 2011 and raised its 1st funding round 4 years after it was founded.

Metactive Medical is headquartered in Olathe, United States. It is registered at Olathe, Kansas, United States.

Metactive Medical is a funded company, having raised a total of $4.7M across 5 funding rounds to date. The company's 1st funding round was a Series A of $2M, raised on Feb 2015.

Metactive Medical has 31 employees.

Metactive Medical was founded in 2011 and is based in Olathe, United States. Endovascular devices are developed for addressing peripheral and neurovascular diseases within the medical technology sector. The initial product is engineered to facilitate occlusion and sealing of cerebral aneurysms along with other vessel segments, utilizing an over-the-wire microcatheter platform. Operations emphasize innovation in vascular interventions for clinical applications.

Metactive Medical's top competitors include Sequent Medical and CoAxia.

Metactive Medical has 5 investors. Key investors include NIH, Mid America Angels, Serra Ventures, National Heart, Lung, and Blood Institute, and Kansas Bioscience Authority.

Metactive Medical operates through Artio Medical, Inc.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available